Catalogue number: | B2700-01A |
Size: | 2ug |
Form: | Supplied as a lyophilized powder from 20mM sodium citrate buffer, pH 5. Reconstitute with sterile ddH2O to (same/more than)100ug/ml, which can then be further diluted to other aqueous solutions. Add 0.1% HSA or BSA for long term storage. |
Purity: | (same/more than) 96% by RP-HPLC or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified. Endotoxin: (same/less than) 0.1ng/ug (IEU/ug) |
References: | 1. Mellstrom B, Torres B, Naranjo JR, Crit Rev Neurobiol 2004;16(1-2):43-9. 2. Imamura L, Kurashina K, Omoteno M, Neurotoxicology 2005 Jan;26(1):17-25. 3. Humbert S, Saudou F, Med Sci (Paris) 2004 Nov;20(11):952-4. 4. Yamada K, Nabeshima T, Drug News Perspect 2004 Sep;17(7):435-8. 5. Savli H, Gulkac MD, Int J Neurosci 2004 Dec;114(12):1601-12. 6. Paskowitz DM, Nune G, Yang H, Zarbin MA, Invest Ophthalmol Vis Sci 2004 Nov; 45(11): 4190-6. |